| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/23/2002 | EP1173429A1 Protease inhibitors |
| 01/23/2002 | EP1173427A1 Hydroxamic acid derivative |
| 01/23/2002 | EP1173424A1 Pyrimidine compounds |
| 01/23/2002 | EP1173415A1 Diphenylurea derivatives |
| 01/23/2002 | EP1173252A1 Products and methods for brachytherapy |
| 01/23/2002 | EP1173201A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173165A1 Cardiovascular and bone treatment using isoflavones |
| 01/23/2002 | EP1173164A2 Estrogen receptor-beta ligands |
| 01/23/2002 | EP1173160A1 (e)-styryl sulfone anticancer agents |
| 01/23/2002 | EP1173154A1 Chewing gum with dental benefits including calcium in a food grade acid |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/23/2002 | CN1332724A N-arylsulfonyl amino acid omega amides |
| 01/23/2002 | CN1332711A Vitamin D analogues |
| 01/23/2002 | CN1332635A Controlled release formulation comprising GnRH-II |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1332004A Fracture setting ointment |
| 01/23/2002 | CN1331998A Ostitis treating capsule |
| 01/23/2002 | CN1331984A External-use trauma treating ointment |
| 01/23/2002 | CN1331983A Hyperosteogeny treating medicine |
| 01/23/2002 | CN1331981A Medicine for treating traumatic injury and relieving pain |
| 01/23/2002 | CN1331980A Hyperosteogeny treating medicine |
| 01/23/2002 | CN1331977A Chinese medicine powder for treating rheumatoid arthritis |
| 01/23/2002 | CN1078083C Bone-calcium liquid protein and its preparation method |
| 01/23/2002 | CN1078081C Medicine for treating osteoproliferation, rheumatism and rheumatoid arthitis, and preparing method thereof |
| 01/23/2002 | CN1078073C Use of bisphophonates in bone-inhibiting reabsorption after transplantation of orthopedic prosthesis |
| 01/22/2002 | US6340703 Treatment or prevention of osteoporosis |
| 01/22/2002 | US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340679 Guanidine derivatives as inhibitors of cell adhesion |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
| 01/22/2002 | CA2214872C Benzothiophene compounds, compositions and methods |
| 01/22/2002 | CA2038848C Hydantoin derivatives |
| 01/17/2002 | WO2002004616A1 RECOMBINANT α-L-IDURONIDASE, METHODS FOR PRODUCING AND PURIFYING THE SAME AND METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES THEREOF |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004472A1 Novel compounds and methods |
| 01/17/2002 | WO2002004459A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 01/17/2002 | WO2002004434A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004427A1 Phenylpyridazine derivatives and drugs containing the same |
| 01/17/2002 | WO2002004426A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 01/17/2002 | WO2002004019A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 01/17/2002 | WO2002004013A1 Remedies for bone diseases |
| 01/17/2002 | WO2002004003A2 Composition for the treatment of osteoarthritis |
| 01/17/2002 | WO2002003992A2 Use of substituted indole compounds for treating prosthesis-related bone degeneration |
| 01/17/2002 | WO2002003980A1 Anti-inflammatory and analgesic agents |
| 01/17/2002 | WO2002003976A2 Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
| 01/17/2002 | WO2002003963A1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient |
| 01/17/2002 | WO2002003920A2 Method for treatment of reactive arthritis or bursitis |
| 01/17/2002 | WO2001049838A3 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 01/17/2002 | WO2001049741A3 A process for isolation of osteopontin from milk |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001047922A3 Azaindoles |
| 01/17/2002 | WO2001046222A3 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 01/17/2002 | WO2001038878A3 Pin1 as a marker for abnormal cell growth |
| 01/17/2002 | WO2001038303A3 Vitamin d analogues |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001016377A3 Diagnostics and therapeutics for osteoporosis |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | US20020007060 Enzyme inhibitors; connective tissue cells; antiarthritic agents; anticarcinogenic agents |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006946 Obesity, antidiabetic agents, cardiovascular disorders |
| 01/17/2002 | US20020006917 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 01/17/2002 | US20020006904 Somatotropin in buffer solution |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006441 Pharmaceutical composition containing diphosphonic acid or salt thereof |
| 01/17/2002 | US20020006432 Bifidobacterium in the treatment of inflammatory disease |
| 01/17/2002 | US20020005205 Joint repair using mesenchymal stem cells |
| 01/17/2002 | DE10032132A1 Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung A dermal therapeutic system containing NSAIDs with selective COX-2 inhibition |
| 01/17/2002 | DE10031651A1 Extrakte aus Sophora-Arten, Verfahren zu ihrer Herstellung und Verwendung Extracts of Sophora species, processes for their preparation and use |
| 01/17/2002 | DE10031650A1 Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden The use of extracts from Sophora flavescens or Sophora subprostrata for the prophylaxis and treatment of pathological conditions caused by estrogen deficiency or by other hormonal dysregulation |
| 01/17/2002 | DE10005302A1 Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/17/2002 | CA2415630A1 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient |
| 01/17/2002 | CA2415052A1 Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2413042A1 Phenylpyridazine derivatives and drugs containing the same |
| 01/17/2002 | CA2411160A1 Colchinol derivatives as vascular damaging agents |
| 01/16/2002 | EP1172361A1 Sulfonamide derivatives having oxadiazole rings |
| 01/16/2002 | EP1172106A2 Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171444A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP1171431A1 Compounds, their preparation and use |
| 01/16/2002 | EP1171424A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | EP1171414A1 Compounds, their preparation and use |
| 01/16/2002 | EP1171161A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 01/16/2002 | EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |